Company Legal Name
Latest Valuation
Founded Year
Headquarter
CMR Surgical Limited develops and manufactures Versius, a next-generation surgical robot system designed for minimally invasive procedures across multiple medical specialties. Founded in 2014 and headquartered in Milton, United Kingdom, the company has positioned itself as a challenger to established surgical robotics platforms by offering a modular, portable system that provides hospitals with greater flexibility and cost-effectiveness. CMR Surgical has secured significant venture funding and achieved regulatory approvals in key markets including Europe and select international territories. The company continues expanding its clinical evidence base while pursuing broader market penetration and additional regulatory clearances globally.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





